Detalhe da pesquisa
1.
Prognostic nutritional index after introduction of atezolizumab with bevacizumab predicts prognosis in advanced hepatocellular carcinoma: A multicenter study.
Oncology
; 2024 Jan 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-38237558
2.
Risk factors for hepatocellular carcinoma at baseline and 1 year after initiation of nucleos(t)ide analog therapy for chronic hepatitis B.
J Med Virol
; 95(1): e28210, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36222204
3.
Effects on survival of the adverse event of atezolizumab plus bevacizumab for hepatocellular carcinoma: a multicenter study by the Japan Red Cross Liver Study Group.
Invest New Drugs
; 41(2): 340-349, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36995548
4.
Outcome of nucleos(t)ide analog cessation in patients with treatment for prevention of or against hepatitis B virus reactivation.
Hepatol Res
; 53(4): 289-300, 2023 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-36461885
5.
The neutrophil-to-lymphocyte ratio at the start of the second course during atezolizumab plus bevacizumab therapy predicts therapeutic efficacy in patients with advanced hepatocellular carcinoma: A multicenter analysis.
Hepatol Res
; 53(6): 511-521, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-36723964
6.
Usefulness of neutrophil-to-lymphocyte ratio in predicting progression and survival outcomes after atezolizumab-bevacizumab treatment for hepatocellular carcinoma.
Hepatol Res
; 53(1): 61-71, 2023 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-36070216
7.
Efficacy of hepatitis C virus eradication after curative treatment for hepatocellular carcinoma in patients with advanced hepatocellular carcinoma and decreased hepatic functional reserve: A nationwide, multicentre study by the Japanese Red Cross Liver Study Group.
J Viral Hepat
; 29(7): 551-558, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35548866
8.
Optimal threshold of alpha-fetoprotein response in patients with unresectable hepatocellular carcinoma treated with atezolizumab and bevacizumab.
Invest New Drugs
; 40(6): 1290-1297, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36152108
9.
Real-world clinical outcomes of sofosbuvir and velpatasvir treatment in HCV genotype 1- and 2-infected patients with decompensated cirrhosis: A nationwide multicenter study by the Japanese Red Cross Liver Study Group.
J Med Virol
; 93(11): 6247-6256, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34170517
10.
Efficacy and safety of glecaprevir/pibrentasvir as retreatment therapy for patients with genotype 2 chronic hepatitis C who failed prior sofosbuvir plus ribavirin regimen.
Hepatol Res
; 49(10): 1121-1126, 2019 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-31209976
11.
Real-world efficacy and safety of sofosbuvir + ribavirin for hepatitis C genotype 2: A nationwide multicenter study by the Japanese Red Cross Liver Study Group.
Hepatol Res
; 49(3): 264-270, 2019 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-30171740
12.
Real-world efficacy of elbasvir and grazoprevir for hepatitis C virus (genotype 1): A nationwide, multicenter study by the Japanese Red Cross Hospital Liver Study Group.
Hepatol Res
; 49(10): 1114-1120, 2019 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-31077527
13.
Genome-Wide Association Study Identifies TLL1 Variant Associated With Development of Hepatocellular Carcinoma After Eradication of Hepatitis C Virus Infection.
Gastroenterology
; 152(6): 1383-1394, 2017 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-28163062
14.
Efficacy of daclatasvir plus asunaprevir in patients with hepatitis C virus infection undergoing and not undergoing hemodialysis.
Hepatol Res
; 48(9): 746-756, 2018 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-29480939
15.
Clinical evaluation of sofosbuvir/ledipasvir in patients with chronic hepatitis C genotype 1 with and without prior daclatasvir/asunaprevir therapy.
Hepatol Res
; 47(12): 1308-1316, 2017 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-28332272
16.
Risk of hepatocellular carcinoma in cirrhotic hepatitis B virus patients during nucleoside/nucleotide analog therapy.
Hepatol Res
; 45(8): 872-9, 2015 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-25244601
17.
Serum interferon-gamma-inducible protein-10 concentrations and IL28B genotype associated with responses to pegylated interferon plus ribavirin with and without telaprevir for chronic hepatitis C.
Hepatol Res
; 44(12): 1208-1216, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-24372894
18.
Noninvasive evaluation of hepatic fibrosis in hepatitis C virus-infected patients using ethoxybenzyl-magnetic resonance imaging.
J Gastroenterol Hepatol
; 28(6): 1032-9, 2013 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-23432660
19.
Novel nasogastric tube-related criteria for urgent endoscopy in nonvariceal upper gastrointestinal bleeding.
Dig Dis Sci
; 58(9): 2564-71, 2013 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-23695871
20.
Case-control study of the RFA therapeutic effect of newly developed 4D US and conventional 2D US.
J Med Ultrason (2001)
; 40(1): 39-46, 2013 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-27276923